Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 128.00 | |
5 mg | In stock | $ 272.00 | |
10 mg | In stock | $ 433.00 | |
25 mg | In stock | $ 722.00 | |
50 mg | In stock | $ 987.00 | |
100 mg | In stock | $ 1,380.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 329.00 |
Description | Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study. |
Synonyms | ABBV-157 |
Molecular Weight | 547.78 |
Formula | C24H20Cl3F3N2O3 |
CAS No. | 2055496-11-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL(365.11 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cedirogant 2055496-11-0 Metabolism ROR Inhibitor inverse RORγt ABBV 157 RAR-related orphan receptor psoriasis ABBV-157 inhibit agonist ABBV157 inhibitor